Monitor future filings for any revenue contribution from this channel partner or updates on partner-driven data delivery volumes. The lack of disclosed financial terms suggests this is a non-material commercial agreement for the near term.
Price Chart
Executive Summary
OneMedNet announced its 12th channel partner agreement with a leading global provider of pharmaceutical intelligence and data solutions, which will distribute OneMedNet's U.S.-sourced, de-identified clinical data to pharmaceutical customers worldwide. The agreement expands OneMedNet's commercial reach through established distribution channels without financial terms disclosed. This is a routine commercial expansion for a small-cap data provider, with no revenue or financial impact figures provided.
Key Facts
- 12th channel partner agreement signed with a leading global provider of pharmaceutical intelligence and data solutions
- Partner will distribute OneMedNet's U.S.-sourced, de-identified clinical data to its pharmaceutical customer base worldwide
- OneMedNet's network spans more than 2,300 sites with over 90 million patient journeys and 270 million studies
- No financial terms, revenue contribution, or upfront payments disclosed in the announcement
Financial Impact
No financial terms disclosed; agreement is a distribution partnership with no stated revenue, upfront payment, or minimum commitment
Risk Factors
- No revenue or financial commitment disclosed, making it difficult to assess materiality
- Channel partner agreements may take quarters to generate meaningful revenue, if at all
- Competition in the real-world data market is intensifying with larger players
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3383450 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 19, 2026 7d ago | Press Release | $4.62 | awaiting T+20 | — | $4.47 (−3.25%) |
Oct 14, 2026 12d ago | 8-K | $4.71 | awaiting T+20 | — | $4.47 (−5.10%) |
Oct 13, 2026 13d ago | Insider Cluster | $4.71 | awaiting T+20 | — | $4.47 (−5.10%) |
Sep 29, 2026 27d ago | 8-K | $5.21 | awaiting T+20 | — | $4.47 (−14.19%) |
Sep 22, 2026 4w ago | Press Release | $0.6500 $0.4748 | ▼ −26.95% | ▼ −26.39% | $4.47 (+587.69%) |
Jul 24, 2026 13w ago | 8-K | $0.6059 $0.5901 | ▼ −2.61% | ▼ −5.91% | $4.47 (+637.75%) |
Jul 13, 2026 15w ago | EFFECT | $0.7457 $0.6600 | ▼ −11.49% | ▼ −14.68% | $4.47 (+499.44%) |
Jun 17, 2026 18w ago | Insider Cluster | $0.6023 $0.6901 | ▲ +14.58% | ▲ +13.26% | $4.47 (+642.16%) |
Jun 16, 2026 19w ago | Insider Cluster | $0.5011 $0.7267 | ▲ +45.02% | ▲ +44.82% | $4.47 (+792.04%) |
Apr 6, 2026 29w ago | Press Release | $0.9520 $1.05 | ▲ +10.29% | ▲ +1.31% | $4.47 (+369.54%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers